Filed 2.8y ago· Aug 13, 2023
32 days to disclose
Daniel S. Goldman
DHouseNew York-10
↓sold
Molina Healthcare
MOH
$1K-$15K
+14.5% vs S&P 500
Trade dateJul 12, 2023
Recent filings
Every politician trade, as it’s filed.
Stock trades that members of the U.S. House and Senate disclose, by law, after they buy or sell. Pulled straight from the official government websites — typically posted within hours of being filed.
Showing 1–28 of 28
Filed 2.8y ago· Aug 13, 2023
32 days to discloseDaniel S. Goldman
DHouseNew York-10
↓sold
UnitedHealth Group
UNH
$15K-$50K
+14.5% vs S&P 500
Trade dateJul 12, 2023
Common Stock
Filed 2.8y ago· Aug 13, 2023
32 days to discloseDaniel S. Goldman
DHouseNew York-10
↓sold
Thermo Fisher Scientific
TMO
$50K-$100K
+14.5% vs S&P 500
Trade dateJul 12, 2023
Filed 2.8y ago· Aug 13, 2023
34 days to discloseDaniel S. Goldman
DHouseNew York-10
↓sold
Fresenius Medical Care Ag
FMS
$1K-$15K
+14.2% vs S&P 500
Trade dateJul 10, 2023
Filed 2.8y ago· Aug 13, 2023
34 days to discloseDaniel S. Goldman
DHouseNew York-10
↓sold
Teleflex
TFX
$15K-$50K
+14.2% vs S&P 500
Trade dateJul 10, 2023
Filed 3.0y ago· May 19, 2023
39 days to discloseDaniel S. Goldman
DHouseNew York-10
↑bought
Insulet
PODD
$15K-$30K
−65.7% vs S&P 500
Trade dateApr 10, 2023
Filed 3.0y ago· May 19, 2023
39 days to discloseDaniel S. Goldman
DHouseNew York-10
↓sold
Inspire Medical Systems
INSP
$1K-$15K
+11.3% vs S&P 500
Trade dateApr 10, 2023
Filed 3.0y ago· May 19, 2023
39 days to discloseDaniel S. Goldman
DHouseNew York-10
↓sold
CVS Health
CVS
$15K-$50K
+11.3% vs S&P 500
Trade dateApr 10, 2023
Filed 3.0y ago· May 19, 2023
39 days to discloseDaniel S. Goldman
DHouseNew York-10
↑bought
Viatris
VTRS
$1K-$15K
+61.2% vs S&P 500
Trade dateApr 10, 2023
Filed 3.1y ago· Apr 17, 2023
41 days to discloseDaniel S. Goldman
DHouseNew York-10
↑bought
Abbott Laboratories
ABT
$1K-$15K
−29.3% vs S&P 500
Trade dateMar 7, 2023
Filed 3.1y ago· Apr 17, 2023
41 days to discloseDaniel S. Goldman
DHouseNew York-10
↓sold
Omega Healthcare Investors
OHI
$1K-$15K
+16.9% vs S&P 500
Trade dateMar 7, 2023
Filed 3.1y ago· Apr 17, 2023
41 days to discloseDaniel S. Goldman
DHouseNew York-10
↑bought
Danaher
DHR
$1K-$15K
−36.2% vs S&P 500
Trade dateMar 7, 2023
Filed 3.1y ago· Apr 17, 2023
42 days to discloseDaniel S. Goldman
DHouseNew York-10
↑bought
Intuitive Surgical
ISRG
$1K-$15K
+56.1% vs S&P 500
Trade dateMar 6, 2023
Filed 3.1y ago· Apr 17, 2023
42 days to discloseDaniel S. Goldman
DHouseNew York-10
↓sold
UnitedHealth Group
UNH
$50K-$100K
+15.0% vs S&P 500
Trade dateMar 6, 2023
Common Stock
Filed 3.1y ago· Apr 17, 2023
42 days to discloseDaniel S. Goldman
DHouseNew York-10
↑bought
Centene
CNC
$15K-$50K
−34.8% vs S&P 500
Trade dateMar 6, 2023
Filed 3.1y ago· Apr 17, 2023
42 days to discloseDaniel S. Goldman
DHouseNew York-10
↓sold
Globus Medical
GMED
$15K-$50K
+15.0% vs S&P 500
Trade dateMar 6, 2023
Globus Medical, Inc. Class A
Filed 3.1y ago· Apr 17, 2023
42 days to discloseDaniel S. Goldman
DHouseNew York-10
↑bought
Edwards Lifesciences
EW
$15K-$50K
−8.4% vs S&P 500
Trade dateMar 6, 2023
Filed 3.1y ago· Apr 17, 2023
42 days to discloseDaniel S. Goldman
DHouseNew York-10
↑bought
Medtronic
MDT
$15K-$50K
−16.4% vs S&P 500
Trade dateMar 6, 2023
Filed 3.1y ago· Apr 17, 2023
42 days to discloseDaniel S. Goldman
DHouseNew York-10
↑bought
Thermo Fisher Scientific
TMO
$1K-$15K
−30.4% vs S&P 500
Trade dateMar 6, 2023
Filed 3.3y ago· Feb 24, 2023
24 days to discloseDaniel S. Goldman
DHouseNew York-10
↓sold
Chemed
CHE
$15K-$50K
+11.4% vs S&P 500
Trade dateJan 31, 2023
Filed 3.3y ago· Feb 24, 2023
24 days to discloseDaniel S. Goldman
DHouseNew York-10
↑bought
CVS Health
CVS
$15K-$50K
−8.9% vs S&P 500
Trade dateJan 31, 2023
Filed 3.3y ago· Feb 24, 2023
24 days to discloseDaniel S. Goldman
DHouseNew York-10
↓sold
ShockWave Medical, Inc
SWAV
$1K-$15K
Trade dateJan 31, 2023
ShockWave Medical
Filed 3.3y ago· Feb 24, 2023
24 days to discloseDaniel S. Goldman
DHouseNew York-10
↓sold
Syneos Health, Inc. -
SYNH
$1K-$15K
Trade dateJan 31, 2023
Filed 3.3y ago· Feb 24, 2023
24 days to discloseDaniel S. Goldman
DHouseNew York-10
↓sold
UnitedHealth Group
UNH
$15K-$50K
+11.4% vs S&P 500
Trade dateJan 31, 2023
Common Stock
Filed 3.3y ago· Feb 24, 2023
24 days to discloseDaniel S. Goldman
DHouseNew York-10
↑bought
Intuitive Surgical
ISRG
$1K-$15K
+52.2% vs S&P 500
Trade dateJan 31, 2023
Filed 3.3y ago· Feb 24, 2023
24 days to discloseDaniel S. Goldman
DHouseNew York-10
↑bought
Medtronic
MDT
$15K-$50K
−19.6% vs S&P 500
Trade dateJan 31, 2023
Filed 3.3y ago· Feb 24, 2023
24 days to discloseDaniel S. Goldman
DHouseNew York-10
↓sold
Centene
CNC
$15K-$50K
+11.4% vs S&P 500
Trade dateJan 31, 2023
Filed 3.3y ago· Feb 24, 2023
42 days to discloseDaniel S. Goldman
DHouseNew York-10
↑bought
Viatris
VTRS
$1K-$15K
+37.6% vs S&P 500
Trade dateJan 13, 2023
| Filed | Politician | Type | Stock | Trade date | Smart move? | Size |
|---|---|---|---|---|---|---|
Aug 13, 2023 2.8y ago | Daniel S. Goldman DHouseNew York-10 | ↓sold | Molina Healthcare MOH | Jul 12, 2023 32 days to disclose | Flat·+0.0% +14.5% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 13, 2023 2.8y ago | Daniel S. Goldman DHouseNew York-10 | ↓sold | UnitedHealth Group UNH Common Stock | Jul 12, 2023 32 days to disclose | Flat·+0.0% +14.5% vs S&P 500 | $15K-$50K midpoint $32.5K |
Aug 13, 2023 2.8y ago | Daniel S. Goldman DHouseNew York-10 | ↓sold | Thermo Fisher Scientific TMO | Jul 12, 2023 32 days to disclose | Flat·+0.0% +14.5% vs S&P 500 | $50K-$100K midpoint $75K |
Aug 13, 2023 2.8y ago | Daniel S. Goldman DHouseNew York-10 | ↓sold | Fresenius Medical Care FMS | Jul 10, 2023 34 days to disclose | Flat·+0.0% +14.2% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 13, 2023 2.8y ago | Daniel S. Goldman DHouseNew York-10 | ↓sold | Teleflex TFX | Jul 10, 2023 34 days to disclose | Flat·+0.0% +14.2% vs S&P 500 | $15K-$50K midpoint $32.5K |
May 19, 2023 3.0y ago | Daniel S. Goldman DHouseNew York-10 | ↑bought | Insulet PODD | Apr 10, 2023 39 days to disclose | Bad buy·−$12.2K-54.4% −65.7% vs S&P 500 | $15K-$30K midpoint $22.5K |
May 19, 2023 3.0y ago | Daniel S. Goldman DHouseNew York-10 | ↓sold | Inspire Medical Systems INSP | Apr 10, 2023 39 days to disclose | Flat·+0.0% +11.3% vs S&P 500 | $1K-$15K midpoint $8K |
May 19, 2023 3.0y ago | Daniel S. Goldman DHouseNew York-10 | ↓sold | CVS Health CVS | Apr 10, 2023 39 days to disclose | Flat·+0.0% +11.3% vs S&P 500 | $15K-$50K midpoint $32.5K |
May 19, 2023 3.0y ago | Daniel S. Goldman DHouseNew York-10 | ↑bought | Viatris VTRS | Apr 10, 2023 39 days to disclose | Good buy·+$5.8K+72.5% +61.2% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | Daniel S. Goldman DHouseNew York-10 | ↑bought | Abbott Laboratories ABT | Mar 7, 2023 41 days to disclose | Bad buy·−$994-12.4% −29.3% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | Daniel S. Goldman DHouseNew York-10 | ↓sold | Omega Healthcare Investors OHI | Mar 7, 2023 41 days to disclose | Flat·+0.0% +16.9% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | Daniel S. Goldman DHouseNew York-10 | ↑bought | Danaher DHR | Mar 7, 2023 41 days to disclose | Bad buy·−$1.5K-19.3% −36.2% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | Daniel S. Goldman DHouseNew York-10 | ↑bought | Intuitive Surgical ISRG | Mar 6, 2023 42 days to disclose | Good buy·+$5.7K+71.1% +56.1% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | Daniel S. Goldman DHouseNew York-10 | ↓sold | UnitedHealth Group UNH Common Stock | Mar 6, 2023 42 days to disclose | Flat·+0.0% +15.0% vs S&P 500 | $50K-$100K midpoint $75K |
Apr 17, 2023 3.1y ago | Daniel S. Goldman DHouseNew York-10 | ↑bought | Centene CNC | Mar 6, 2023 42 days to disclose | Bad buy·−$6.4K-19.8% −34.8% vs S&P 500 | $15K-$50K midpoint $32.5K |
Apr 17, 2023 3.1y ago | Daniel S. Goldman DHouseNew York-10 | ↓sold | Globus Medical GMED Globus Medical, Inc. Class A | Mar 6, 2023 42 days to disclose | Flat·+0.0% +15.0% vs S&P 500 | $15K-$50K midpoint $32.5K |
Apr 17, 2023 3.1y ago | Daniel S. Goldman DHouseNew York-10 | ↑bought | Edwards Lifesciences EW | Mar 6, 2023 42 days to disclose | Good buy·+$2.1K+6.6% −8.4% vs S&P 500 | $15K-$50K midpoint $32.5K |
Apr 17, 2023 3.1y ago | Daniel S. Goldman DHouseNew York-10 | ↑bought | Medtronic MDT | Mar 6, 2023 42 days to disclose | Bad buy·−$436-1.3% −16.4% vs S&P 500 | $15K-$50K midpoint $32.5K |
Apr 17, 2023 3.1y ago | Daniel S. Goldman DHouseNew York-10 | ↑bought | Thermo Fisher Scientific TMO | Mar 6, 2023 42 days to disclose | Bad buy·−$1.2K-15.3% −30.4% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 24, 2023 3.3y ago | Daniel S. Goldman DHouseNew York-10 | ↓sold | Chemed CHE | Jan 31, 2023 24 days to disclose | Flat·+0.0% +11.4% vs S&P 500 | $15K-$50K midpoint $32.5K |
Feb 24, 2023 3.3y ago | Daniel S. Goldman DHouseNew York-10 | ↑bought | CVS Health CVS | Jan 31, 2023 24 days to disclose | Good buy·+$805+2.5% −8.9% vs S&P 500 | $15K-$50K midpoint $32.5K |
Feb 24, 2023 3.3y ago | Daniel S. Goldman DHouseNew York-10 | ↓sold | ShockWave Medical, Inc SWAV ShockWave Medical | Jan 31, 2023 24 days to disclose | price pending | $1K-$15K midpoint $8K |
Feb 24, 2023 3.3y ago | Daniel S. Goldman DHouseNew York-10 | ↓sold | Syneos Health, Inc. - SYNH | Jan 31, 2023 24 days to disclose | price pending | $1K-$15K midpoint $8K |
Feb 24, 2023 3.3y ago | Daniel S. Goldman DHouseNew York-10 | ↓sold | UnitedHealth Group UNH Common Stock | Jan 31, 2023 24 days to disclose | Flat·+0.0% +11.4% vs S&P 500 | $15K-$50K midpoint $32.5K |
Feb 24, 2023 3.3y ago | Daniel S. Goldman DHouseNew York-10 | ↑bought | Intuitive Surgical ISRG | Jan 31, 2023 24 days to disclose | Good buy·+$5.1K+63.5% +52.2% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 24, 2023 3.3y ago | Daniel S. Goldman DHouseNew York-10 | ↑bought | Medtronic MDT | Jan 31, 2023 24 days to disclose | Bad buy·−$2.7K-8.2% −19.6% vs S&P 500 | $15K-$50K midpoint $32.5K |
Feb 24, 2023 3.3y ago | Daniel S. Goldman DHouseNew York-10 | ↓sold | Centene CNC | Jan 31, 2023 24 days to disclose | Flat·+0.0% +11.4% vs S&P 500 | $15K-$50K midpoint $32.5K |
Feb 24, 2023 3.3y ago | Daniel S. Goldman DHouseNew York-10 | ↑bought | Viatris VTRS | Jan 13, 2023 42 days to disclose | Good buy·+$3.8K+47.2% +37.6% vs S&P 500 | $1K-$15K midpoint $8K |